Human Longevity
PrivateLast Round
Series B
Aug 20, 2024
Est. Valuation
$310M
Total Funding Raised
$399.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Human Longevity is a biotechnology company that offers a platform integrating genomic and phenotypic data to enhance the understanding of human health and proactively address age-related health issues through advanced DNA sequencing and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical Imaging, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2C
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Human Longevity Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Human Longevity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 20, 2024 | ||||
| Series C | Nov 6, 2019 | ||||
| Series C | Dec 7, 2018 | ||||
| Series B | Apr 4, 2016 | ||||
| Series A | Mar 4, 2014 |
Key People
Founding team and executive leadership
Human Longevity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emerging Technology Partners | Series B, Series C |
| Threshold Ventures | Series A |
| OS Fund | Series B, Series A |
| TVM Capital Healthcare | Series B |
| Panacea Venture Healthcare | Series B |
| GE Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Nobel Prize-winning scientist Geoffrey Hinton joins as Scientific Advisor.
- Mar 25, 2026
Partnered with Longevity Escape Velocity Foundation to study human aging.
Human Longevity Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Human Longevity's valuation, stock price, and market status.